Inflammation induced by infection potentiates tau pathological features in transgenic mice

American Journal of Pathology

Volumn 178, Issue 6, 2011, Pages 2811-2822

  Sy, Michael ^a,b   Kitazawa, Masashi ^a,b   Medeiros, Rodrigo ^a,b   Whitman, Lucia ^a   Cheng, David ^a,b   Lane, Thomas E ^a   LaFerla, Frank M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LIPOPOLYSACCHARIDE; LITHIUM; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; CHRONIC INFLAMMATION; COMORBIDITY; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; INFLAMMATION; LEARNING DISORDER; MALE; MEMORY DISORDER; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPATIAL MEMORY; TRANSGENIC MOUSE; VIRUS INFECTION;

EID: 79959379859     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2011.02.012     Document Type: Article

References (55)

1. Selkoe DJ: Toward a remembrance of things past: deciphering Alzheimer disease. Harvey Lect 2003, 99:23-45
2. Itagaki S, McGeer PL, Akiyama H, Zhu S, Selkoe D: Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989, 24:173-182 (Pubitemid 19271472)
3. McGeer PL, Rogers J, McGeer EG: Inflammation, anti-inflammatory agents and Alzheimer disease: the last 12 years. J Alzheimers Dis 2006, 9:271-276 (Pubitemid 44253320)
4. Rogers J, Lue LF: Microglial chemotaxis, activation, and phagocytosis of amyloid beta-peptide as linked phenomena in Alzheimer's disease. Neurochem Int 2001, 39:333-340 (Pubitemid 32907397)
5. Rothman SM, Mattson MP: Adverse stress, hippocampal networks, and Alzheimer's disease. Neuromolecular Med 2010, 12:56-70
6. Viswanathan A, Rocca WA, Tzourio C: Vascular risk factors and dementia: how to move forward? Neurology 2009, 72:368-374
7. Holmes C, Cotterell D: Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment. CNS Drugs 2009, 23: 993-1002
8. Honjo K, van Reekum R, Verhoeff NP: Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement 2009, 5:348-360
9. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, Abrams JT, Whittum-Hudson JA, Hudson AP: Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med Microbiol Immunol 1998, 187:23-42 (Pubitemid 28383127)
10. Kountouras J, Tsolaki M, Gavalas E, Boziki M, Zavos C, Karatzoglou P, Chatzopoulos D, Venizelos I: Relationship between Helicobacter pylori infection and Alzheimer disease. Neurology 2006, 66:938-940 (Pubitemid 43739779)
11. Itzhaki RF, Wozniak MA: Herpes simplex virus type 1 in Alzheimer's disease: the enemy within. J Alzheimers Dis 2008, 13:393-405 (Pubitemid 352039023)
12. Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM: Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol Aging 2004, 25:419-429 (Pubitemid 38317339)
13. Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB: Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci Lett 2007, 429:95-100 (Pubitemid 350161114)
14. Brugg B, Dubreuil YL, Huber G, Wollman EE, Delhaye-Bouchaud N, Mariani J: Inflammatory processes induce beta-amyloid precursor protein changes in mouse brain. Proc Natl Acad Sci U S A 1995, 92:3032-3035
15. Kitazawa M, Oddo S, Yamasaki TR, Green KN, LaFerla FM: Lipopolysaccharide- induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J Neurosci 2005, 25:8843-8853 (Pubitemid 41384452)
16. Sheng JG, Bora SH, Xu G, Borchelt DR, Price DL, Koliatsos VE: Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol Dis 2003, 14:133-145 (Pubitemid 37103187)
17. Wyss-Coray T: Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med 2006, 12:1005-1015 (Pubitemid 44353380)
18. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD: Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J Neurosci Res 1996, 43:190-202 (Pubitemid 26044233)
19. Akiyama H, Schwab C, Kondo H, Mori H, Kametani F, Ikeda K, McGeer PL: Granules in glial cells of patients with Alzheimer's disease are immunopositive for C-terminal sequences of beta-amyloid protein. Neurosci Lett 1996, 206:169-172 (Pubitemid 26094686)
20. Herber DL, Roth LM, Wilson D, Wilson N, Mason JE, Morgan D, Gordon MN: Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice. Exp Neurol 2004, 190:245-253 (Pubitemid 39335723)
21. Herber DL, Mercer M, Roth LM, Symmonds K, Maloney J, Wilson N, Freeman MJ, Morgan D, Gordon MN: Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J Neuroimmune Pharmacol 2007, 2:222-231
22. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, Geula C, Luster AD: Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 2007, 13: 432-438 (Pubitemid 46559828)
23. Wyss-Coray T, Yan F, Lin AH, Lambris JD, Alexander JJ, Quigg RJ, Masliah E: Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice. Proc Natl Acad Sci U S A 2002, 99:10837-10842
24. Lee JW, Lee YK, Yuk DY, Choi DY, Ban SB, Oh KW, Hong JT: Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J Neuroinflammation 2008, 5:37
25. Griffin WS, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, Roberts GW, Mrak RE: Glial-neuronal interactions in Alzheimer's disease: the potential role of a "cytokine cycle" in disease progression. Brain Pathol 1998, 8:65-72 (Pubitemid 28055765)
26. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T: Inflammation and Alzheimer's disease. Neurobiol Aging 2000, 21:383-421 (Pubitemid 30349107)
27. Li Y, Liu L, Barger SW, Griffin WS: Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway. J Neurosci 2003, 23:1605-1611 (Pubitemid 36314715)
28. Quintanilla RA, Orellana DI, Gonzalez-Billault C, Maccioni RB: Interleukin- 6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway. Exp Cell Res 2004, 295:245-257 (Pubitemid 38407361)
29. Stiles LN, Hardison JL, Schaumburg CS, Whitman LM, Lane TE: T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection. J Immunol 2006, 177:8372-8380 (Pubitemid 44893799)
30. Walsh KB, Lodoen MB, Edwards RA, Lanier LL, Lane TE: Evidence for differential roles for NKG2D receptor signaling in innate host defense against coronavirus-induced neurological and liver disease. J Virol 2008, 82:3021-3030 (Pubitemid 351329190)
31. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ: Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 1998, 160:970-978 (Pubitemid 28049342)
32. Totoiu MO, Nistor GI, Lane TE, Keirstead HS: Remyelination, axonal sparing, and locomotor recovery following transplantation of glialcommitted progenitor cells into the MHV model of multiple sclerosis. Exp Neurol 2004, 187:254-265 (Pubitemid 38610272)
33. Wang FI, Stohlman SA, Fleming JO: Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol 1990, 30:31-41 (Pubitemid 20324754)
34. McAlpine FE, Lee JK, Harms AS, Ruhn KA, Blurton-Jones M, Hong J, Das P, Golde TE, LaFerla FM, Oddo S, Blesch A, Tansey MG: Inhibition of soluble TNF signaling in a mouse model of Alzheimer's disease prevents pre-plaque amyloid-associated neuropathology. Neurobiol Dis 2009, 34:163-177
35. Zheng-Fischhofer Q, Biernat J, Mandelkow EM, Illenberger S, Godemann R, Mandelkow E: Sequential phosphorylation of tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem 1998, 252:542-552 (Pubitemid 28156880)
36. Kitazawa M, Trinh DN, LaFerla FM: Inflammation induces tau pathology in inclusion body myositis model via glycogen synthase kinase-3beta. Ann Neurol 2008, 64:15-24
37. Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM: Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 2007, 337-351 (Pubitemid 46161268)
38. Sahara N, Maeda S, Takashima A: Tau oligomerization: a role for tau aggregation intermediates linked to neurodegeneration. Curr Alzheimer Res 2008, 5:591-598
39. Wen Y, Planel E, Herman M, Figueroa HY, Wang L, Liu L, Lau LF, Yu WH, Duff KE: Interplay between cyclin-dependent kinase 5 and glycogen synthase kinase 3 beta mediated by neuregulin signaling leads to differential effects on tau phosphorylation and amyloid precursor protein processing. J Neurosci 2008, 28:2624-2632 (Pubitemid 351348188)
40. Oddo S, Caccamo A, Cheng D, Jouleh B, Torp R, LaFerla FM: Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice. J Neurochem 2007, 102:1053-1063 (Pubitemid 47174220)
41. Plattner F, Angelo M, Giese KP: The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation. J Biol Chem 2006, 281:25457-25465 (Pubitemid 44401934)
42. Fu AK, Fu WY, Cheung J, Tsim KW, Ip FC, Wang JH, Ip NY: Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction. Nat Neurosci 2001, 4:374-381 (Pubitemid 32260113)
43. Arnaud L, Robakis NK, Figueiredo-Pereira ME: It may take inflammation, phosphorylation and ubiquitination to "tangle" in Alzheimer's disease. Neurodegener Dis 2006, 3:313-319 (Pubitemid 46034207)
44. Caccamo A, Oddo S, Tran LX, LaFerla FM: Lithium reduces tau phosphorylation but not A beta or working memory deficits in a transgenic model with both plaques and tangles. Am J Pathol 2007, 170:1669-1675 (Pubitemid 47339311)
45. Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K: Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A 1997, 94:298-303
46. Evans DB, Rank KB, Bhattacharya K, Thomsen DR, Gurney ME, Sharma SK: Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly. J Biol Chem 2000, 275:24977-24983 (Pubitemid 30626606)
47. Mandelkow EM, Stamer K, Vogel R, Thies E, Mandelkow E: Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses. Neurobiol Aging 2003, 24:1079-1085 (Pubitemid 37487885)
48. Kimura T, Yamashita S, Nakao S, Park JM, Murayama M, Mizoroki T, Yoshiike Y, Sahara N, Takashima A: GSK-3beta is required for memory reconsolidation in adult brain. PLoS One 2008, 3:e3540
49. Wang Y, Zhang JX, Du XX, Zhao L, Tian Q, Zhu LQ, Wang SH, Wang JZ: Temporal correlation of the memory deficit with Alzheimer-like lesions induced by activation of glycogen synthase kinase-3. J Neurochem 2008, 106:2364-2374
50. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA: Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 1995, 378:785-789 (Pubitemid 26004411)
51. Mora A, Sabio G, Risco AM, Cuenda A, Alonso JC, Soler G, Centeno F: Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2A. Cell Signal 2002, 14:557-562 (Pubitemid 34230591)
52. Sarkar S, Floto RA, Berger Z, Imarisio S, Cordenier A, Pasco M, Cook LJ, Rubinsztein DC: Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 2005, 170:1101-1111 (Pubitemid 41362642)
53. Fornai F, Longone P, Cafaro L, Kastsiuchenka O, Ferrucci M, Manca ML, Lazzeri G, Spalloni A, Bellio N, Lenzi P, Modugno N, Siciliano G, Isidoro C, Murri L, Ruggieri S, Paparelli A: Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A 2008, 105:2052-2057 (Pubitemid 351439463)
54. Heiseke A, Aguib Y, Riemer C, Baier M, Schatzl HM: Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J Neurochem 2009, 109:25-34
55. Jimenez S, Baglietto-Vargas D, Caballero C, Moreno-Gonzalez I, Torres M, Sanchez-Varo R, Ruano D, Vizuete M, Gutierrez A, Vitorica J: Inflammatory response in the hippocampus of PS1M146L/ APP751SL mouse model of Alzheimer's disease: age-dependent switch in the microglial phenotype from alternative to classic. J Neurosci 2008, 28:11650-11661